Valeur20202021202220232024TTMFrais de vente, généraux et administratifs670.39 M739.37 M874 M917.14 M991.02 M1.09 BRecherche et développement225.28 M253.57 M287.64 M307.52 M331.28 M359 MRésultat d'exploitation903.68 M1 B1.13 B1.32 B1.69 B1.89 BTotal des produits hors exploitation-20.02 M-39.8 M-30.21 M-55.09 M-7.8 M10.76 MCharges d'intérêts, nettes des intérêts capitalisés23.99 M—————Résultat hors exploitation, hors charges d'intérêts-58.82 M-43 M-24.5 M-51.6 M-2.54 M22.23 MRevenus/dépenses exceptionnels14.82 M3.2 M-5.71 M-3.49 M-5.26 M-11.47 MRésultat avant impôts883.66 M960.48 M1.1 B1.26 B1.68 B1.9 BPart des actionnaires dans le résultat-11.21 M-8.49 M-7.26 M-1.85 M3.64 M5.99 MImpôts409.16 M181.05 M204.11 M243.85 M276.84 M383.74 MIntérêts ne donnant pas le contrôle / intérêts minoritaires——————Autres produits/charges après impôts——————Résultat net avant activités abandonnées474.5 M779.44 M897.56 M1.02 B1.4 B1.52 BActivités abandonnées——————Résultat net474.5 M779.44 M897.56 M1.02 B1.4 B1.52 BAjustement de dilution——————Dividendes privilégiés——————Résultat net dilué revenant aux actionnaires ordinaires474.5 M779.44 M897.56 M1.02 B1.4 B1.52 BBénéfice par action de base (BPA de base)3.275.346.126.949.5510.4Bénéfice par action dilué (BPA dilué)3.245.36.096.929.5110.37Nombre moyen d'actions de base en circulation145.31 M146.07 M146.76 M147.02 M146.72 M—Nombre d'actions en circulation après dilution146.45 M147.04 M147.46 M147.55 M147.34 M—EBITDA1.06 B1.18 B1.34 B1.5 B1.88 B2.11 BEBIT903.68 M977.97 M1.08 B1.32 B1.69 B1.89 BCoût des ventes1.36 B1.55 B1.87 B2.03 B2.09 B2.13 BAutres coûts des ventes1.31 B1.51 B1.84 B2 B2.06 B2.09 BAmortissements (flux de trésorerie)156.76 M159.61 M165.16 M176.87 M198.47 M220.19 M
ResMed Inc. Common Stock
ResMed Inc. is a medical equipment company based in San Diego, California, and founded in Australia. It primarily provides cloud-connectable medical devices for the treatment of sleep apnea, chronic obstructive pulmonary disease, and other respiratory conditions. Resmed produced hundreds of thousands of ventilators and bilevel devices to help treat the respiratory symptoms of patients with COVID-19. Resmed also provides software to out-of-hospital care agencies to streamline transitions of care into and between these care settings for seniors and their care providers.
Resmed employs more than 8,000 people worldwide as of June 2022. The company operates in more than 140 countries worldwide, and has manufacturing facilities in Australia, Singapore, France, and the United States. Revenue was US$4.7 billion in fiscal year 2024.